Ionis Pharmaceuticals IONS
NASDAQ IONS
$44.00 -0.65 (-1.46%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ionis Pharmaceuticals (IONS) Gross Profit (2018 - 2026)

Updated

Ionis Pharmaceuticals (IONS) recorded Gross Profit of $265.21 million in Q2 2026, down 40.8% from $447.9 million a year earlier but up 9.1% from the prior quarter.

Analysis

Ionis Pharmaceuticals (IONS) Gross Profit (2018 - 2026) Analysis & Trends

On a TTM basis, Ionis Pharmaceuticals' Gross Profit came in at $858.07 million as of Jun 30, 2026, down 8.1% year-over-year; for FY2025, it was $927.8 million, up 33.7% from FY2024.

  • Annual Gross Profit has a five-year compound annual growth rate of 5.3% (FY2020 to FY2025).
  • Across earlier years, Gross Profit came in at $693.92 million in FY2024 (-10.9%), $778.51 million in FY2023 (+35.8%), $573.25 million in FY2022 (-28.3%) and $799.61 million in FY2021 (+11.5%).
  • Quarterly Gross Profit has ranged from $117.35 million in Q1 2024 to $447.9 million in Q2 2025 over the past five years.
  • On a year-over-year basis, Gross Profit rose in four of the last eight quarters, with growth averaging 15.8%.
  • Peak year-over-year performance for Gross Profit in the last five years was growth of 116.9% in Q4 2023, against a decline of 66.1% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $243.11 million (Q1 2026), $195.37 million (Q4 2025) and $154.38 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

Ionis Pharmaceuticals Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=IONS&period=max&api_key=YOUR_API_KEY